Prof.Dr.med. ID: 71876
Volkmar Müller
Publications
- 2013
Gastropleural fistula in a patient with recurrent ovarian cancer receiving combination therapy with Carboplatin, gemcitabine, and bevacizumab
Dohrmann, T., Kutup, A., Mahner, S., Müller, V., Jänicke, F., Izbicki, J. & Vashist, Y. K., 20.04.2013, In: J CLIN ONCOL. 31, 12, p. e208-10Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01)
Pestalozzi, B. C., Holmes, E., de Azambuja, E., Metzger-Filho, O., Hogge, L., Scullion, M., Láng, I., Wardley, A., Lichinitser, M., Sanchez, R. I. L., Müller, V., Dodwell, D., Gelber, R. D., Piccart-Gebhart, M. J. & Cameron, D., 01.03.2013, In: LANCET ONCOL. 14, 3, p. 244-8 5 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer
Harbeck, N., Beckmann, M. W., Rody, A., Schneeweiss, A., Müller, V., Fehm, T., Marschner, N., Gluz, O., Schrader, I., Heinrich, G., Untch, M. & Jackisch, C., 01.03.2013, In: BREAST CARE. 8, 1, p. 49-55 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Heterogeneity of estrogen receptor expression in circulating tumor cells from metastatic breast cancer patients
Babayan, A., Hannemann, J., Spötter, J., Müller, V., Pantel, K. & Joosse, S. A., 01.01.2013, In: PLOS ONE. 8, 9, p. e75038Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Platelet-derived growth factor receptor beta serum concentrations during first-line therapy in ovarian cancer
Mathey, S., Graeser, M. K., Zu Eulenburg, C., Woelber, L., Trillsch, F., Jänicke, F., Müller, V., Milde-Langosch, K. & Mahner, S., 01.01.2013, In: ONCOLOGY-BASEL. 85, 2, p. 69-77 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials.
Bidard, F-C., Fehm, T., Ignatiadis, M., Smerage, J. B., Alix-Panabières, C., Janni, W., Messina, C., Paoletti, C., Müller, V., Hayes, D. F., Piccart, M. & Pierga, J-Y., 2013, In: CANCER METAST REV. 32, 1-2, p. 179-188 1-2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
HER2-positive Mammakarzinome
Müller, V., 2013, Colloqium Senologie 2013. Untch, M., Harbeck, N., Thomssen, C. & Costa, S. D. (eds.). 1 ed. München: Agilium Verlag und Gesundheitsakademie GmbH, p. 115-132 18 p.Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review
Impressions from the san antonio breast cancer symposium december 2012
Müller, V., Fehm, T., Kümmel, S., Liedtke, C., Rack, B. & Steger, G., 2013, In: BREAST CARE. 8, 1, p. 77-83Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Neoadjuvante Therapie des Mammakarzinoms
Müller, V. & Harbeck, N., 2013, Aktuelle Empfehlungen zur Prävention, Diagnostik und Therapie früher und fortgeschrittener Mammakarzinome. Scharl, A. (ed.). 6 ed. München: W. Zuckschwerdt Verlag, p. 151-165 15 p.Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review
Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.
Burandt, E. C., Jens, G., Holst, F., Jänicke, F., Müller, V., Quaas, A., Choschzick, M., Wilczak, W., Terracciano, L., Simon, R., Sauter, G. & Lebeau, A., 2013, In: BREAST CANCER RES TR. 137, 3, p. 745-753 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients
Schröder, C., Milde-Langosch, K., Gebauer, F., Schmid, K., Müller, V., Wirtz, R. M., Meyer-Schwesinger, C., Schluter, H., Sauter, G. & Schumacher, U., 2013, In: J CANCER RES CLIN. 139, p. 1745-1755 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer.
Wallwiener, M., Hartkopf, A. D., Baccelli, I., Riethdorf, S., Schott, S., Pantel, K., Marmé, F., Sohn, C., Trumpp, A., Rack, B., Aktas, B., Solomayer, E-F., Müller, V., Janni, W., Schneeweiss, A. & Fehm, T. N., 2013, In: BREAST CANCER RES TR. 137, 2, p. 503-510 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.
Milde-Langosch, K., Karn, T., Müller, V., Witzel, I., Rody, A., Schmidt, M. & Wirtz, R. M., 2013, In: BREAST CANCER RES TR. 137, 1, p. 57-67 1.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Zirkulierende Tumorzellen in der Diagnose und Therapie des Mammakarzinoms
Fehm, T., Hartkopf, A. D., Janni, W., Solomayer, E., Rack, B. & Müller, V., 2013, In: BREAST CARE. 8, p. 375-377Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
- 2012
A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumors.
Schmidt, M., Hellwig, B., Hammad, S., Othman, A., Lohr, M., Chen, Z., Boehm, D., Gebhard, S., Petry, I., Lebrecht, A., Cadenas, C., Marchan, R., Stewart, J. D., Solbach, C., Holmberg, L., Edlund, K., Kultima, H. G., Rody, A., Berglund, A., Lambe, M., Isaksson, A., Botling, J., Karn, T., Müller, V., Gerhold-Ay, A., Cotarelo, C., Sebastian, M., Kronenwett, R., Bojar, H., Lehr, H-A., Sahin, U., Koelbl, H., Gehrmann, M., Micke, P., Rahnenführer, J. & Hengstler, J. G., 2012, In: CLIN CANCER RES. 18, 9, p. 2695-2703 9.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells.
Joosse, S., Hannemann, J., Spötter, J., Bauche, A., Andreas, A., Müller, V. & Pantel, K., 2012, In: CLIN CANCER RES. 18, 4, p. 993-1003 4.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.
Witzel, I., Schröder, C., Müller, V., Zander, H., Tachezy, M., Henningsen, M., Jänicke, F. & Milde-Langosch, K., 2012, In: ONCOLOGY-BASEL. 82, 6, p. 305-312 6.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.
Schwarzenbach, H., Milde-Langosch, K., Steinbach, B., Müller, V. & Pantel, K., 2012, In: BREAST CANCER RES TR. 134, 3, p. 933-941 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation.
Karn, T., Pusztai, L., Ruckhäberle, E., Liedtke, C., Müller, V., Schmidt, M., Metzler, D., Wang, J., Coombes, K. R., Gätje, R., Hanker, L., Solbach, C., Ahr, A., Holtrich, U., Rody, A. & Kaufmann, M., 2012, In: EUR J CANCER. 48, 1, p. 12-23 1.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trial.
Witzel, I., Loibl, S., von Minckwitz, G., Eidtmann, H., Fehm, T., Khandan, F., Schmatloch, S., Hauschild, M., Bischoff, J., Fasching, P. A., Mau, C., Schem, C., Rack, B., Meinhold-Heerlein, I., Liedtke, C., Karn, T., Huober, J., Zu Eulenburg, C. G., Issa-Nummer, Y., Untch, M. & Müller, V., 2012, In: BRIT J CANCER. 107, 6, p. 956-960 6.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study.
Müller, V., Riethdorf, S., Rack, B., Janni, W., Fasching, P. A., Solomayer, E., Aktas, B., Kasimir-Bauer, S., Pantel, K., Fehm, T. & Group, O. B. O. T. DETECT. S., 2012, In: BREAST CANCER RES. 14, 4, p. 118 4.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.
Henningsen, M., Kress, K., Kersten, J. F., Kilic, E., Choschzick, M., Zander, H., Müller, V., Mahner, S., Jänicke, F., Wölber, L. & Milde-Langosch, K., 2012, In: BMC CANCER. 12, p. 140Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Relevance of PTEN loss in brain metastasis formation in breast cancer patients.
Wikman, H., Lamszus, K., Detels, N., Uslar, L., Wrage, M., Benner, C., Hohensee, I., Ylstra, B., Eylmann, K., Zapatka, M., Sauter, G., Kemming, D., Glatzel, M., Müller, V., Westphal, M. & Pantel, K., 2012, In: BREAST CANCER RES. 14, 2, p. 49 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Treatment of breast cancer during pregnancy: an observational study.
Loibl, S., Han, S. N., von Minckwitz, G., Bontenbal, M., Ring, A., Giermek, J., Fehm, T., Kristel, V. C., Linn, S. C., Schlehe, B., Gziri, M. M., Westenend, P. J., Müller, V., Heyns, L., Rack, B., Ben, V. C., Harbeck, N., Lenhard, M., Halaska, M. J., Kaufmann, M., Nekljudova, V. & Amant, F., 2012, In: LANCET ONCOL. 13, 9, p. 887-896 9.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Weekly nab-Paclitaxel in Metastatic Breast Cancer - Summary and Results of an Expert Panel Discussion.
Jackisch, C., Lück, H-J., Untch, M., Bischoff, J., Müller, V., Schmidt, M., Thill, M. & Kiechle, M., 2012, In: BREAST CARE. 7, 2, p. 137-143 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2011
A clinically relevant gene signature in triple negative and basal-like breast cancer.
Rody, A., Karn, T., Liedtke, C., Pusztai, L., Ruckhaeberle, E., Hanker, L., Gaetje, R., Solbach, C., Ahr, A., Metzler, D., Schmidt, M., Müller, V., Holtrich, U. & Kaufmann, M., 2011, In: BREAST CANCER RES. 13, 5, p. 97 5.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.
Filipits, M., Rudas, M., Jakesz, R., Dubsky, P., Fitzal, F., Singer, C. F., Dietze, O., Greil, R., Jelen, A., Sevelda, P., Freibauer, C., Müller, V., Jänicke, F., Schmidt, M., Kölbl, H., Rody, A., Kaufmann, M., Schroth, W., Brauch, H., Schwab, M., Fritz, P., Weber, K. E., Feder, I. S., Hennig, G., Kronenwett, R., Gehrmann, M., Gnant, M. & Investigators, EP., 2011, In: CLIN CANCER RES. 17, 18, p. 6012-6020 18.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression.
Roth, C., Pantel, K., Müller, V., Rack, B., Kasimir-Bauer, S., Janni, W. & Schwarzenbach, H., 2011, In: BMC CANCER. 11, p. 4Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein, S., Müller, V., Köhler, N., Wikman, H., Krenkel, S., Streichert, T., Schweizer, M., Riethdorf, S., Assmann, V., Henningsen, M., Beck, K., Issa, R., Jänicke, F., Pantel, K. & Milde-Langosch, K., 2011, In: BREAST CANCER RES TR. 129, 2, p. 347-360 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer.
Wölber, L., Kress, K., Kersten, J. F., Choschzick, M., Kilic, E., Herwig, U., Lindner, C., Schwarz, J., Jänicke, F., Mahner, S., Milde-Langosch, K., Müller, V. & Henningsen, M., 2011, In: BMC CANCER. 11, p. 12Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Circulating microRNAs: promising breast cancer biomarkers - author´s response
Roth, C., Rack, B., Müller, V., Janni, W., Pantel, K. & Schwarzenbach, H., 2011, In: BREAST CANCER RES. 13, 1, p. 403Research output: SCORING: Contribution to journal › Newspaper articles › Transfer
Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients.
Aktas, B., Müller, V., Tewes, M., Zeitz, J., Kasimir-Bauer, S., Loehberg, C. R., Rack, B., Schneeweiss, A. & Fehm, T., 2011, In: GYNECOL ONCOL. 122, 2, p. 356-360 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33).
Loibl, S., Müller, V., von Minckwitz, G., Conrad, B., Koehne, C-H., Kremers, S., Forstbauer, H., Linder, M., Nekljudova, V. & Moebus, V., 2011, In: SUPPORT CARE CANCER. 19, 11, p. 1789-1795 11.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Evaluation of cell-free tumour DNA and RNA in patients with breast cancer and benign breast disease.
Schwarzenbach, H., Müller, V., Milde-Langosch, K., Steinbach, B. & Pantel, K., 2011, In: MOL BIOSYST. 7, 10, p. 2848-2854 10.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance.
Karn, T., Ruckhäberle, E., Hanker, L., Müller, V., Schmidt, M., Solbach, C., Gätje, R., Gehrmann, M., Holtrich, U., Kaufmann, M. & Rody, A., 2011, In: BREAST CANCER RES TR. 130, 2, p. 409-420 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.
Karn, T., Pusztai, L., Holtrich, U., Iwamoto, T., Shiang, C. Y., Schmidt, M., Müller, V., Solbach, C., Gaetje, R., Hanker, L., Ahr, A., Liedtke, C., Ruckhäberle, E., Kaufmann, M. & Rody, A., 2011, In: PLOS ONE. 6, 12, p. 28403 12.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials.
von Minckwitz, G., Untch, M., Nüesch, E., Loibl, S., Kaufmann, M., Kümmel, S., Fasching, P. A., Eiermann, W., Blohmer, J-U., Costa, S. D., Mehta, K., Hilfrich, J., Jackisch, C., Gerber, B., Andreas, D. B., Huober, J., Hanusch, C., Konecny, G., Fett, W., Stickeler, E., Harbeck, N., Müller, V. & Jüni, P., 2011, In: BREAST CANCER RES TR. 125, 1, p. 145-156 1.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Management of patients with brain metastases receiving trastuzumab treatment for metastatic breast cancer.
Witzel, I., Kantelhardt, E. J., Milde-Langosch, K., Henningsen, M., Zeitz, J., Harbeck, N., Jänicke, F. & Müller, V., 2011, In: ONKOLOGIE. 34, 6, p. 304-308 6.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer.
Choschzick, M., Oosterwijk, E., Müller, V., Wölber, L., Simon, R., Moch, H. & Tennstedt, P., 2011, In: VIRCHOWS ARCH. 459, 2, p. 193-200 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups.
Untch, M., Fasching, P. A., Konecny, G. E., Hasmüller, S., Lebeau, A., Kreienberg, R., Camara, O., Müller, V., Andreas, D. B., Kühn, T., Stickeler, E., Harbeck, N., Höss, C., Kahlert, S., Beck, T., Fett, W., Mehta, K. M., von Minckwitz, G. & Loibl, S., 2011, In: J CLIN ONCOL. 29, 25, p. 3351-3357 25.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer--results at the time of surgery.
Untch, M., Fasching, P. A., Konecny, G. E., von Koch, F., Conrad, U., Fett, W., Kurzeder, C., Lück, H-J., Stickeler, E., Urbaczyk, H., Liedtke, B., Salat, C., Harbeck, N., Müller, V., Schmidt, M., Hasmüller, S., Lenhard, M., Schuster, T., Nekljudova, V., Lebeau, A., Loibl, S., von Minckwitz, G. & Investigators, A. G. O. PREPARE., 2011, In: ANN ONCOL. 22, 9, p. 1988-1998 9.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer--outcome on prognosis.
Untch, M., von Minckwitz, G., Konecny, G. E., Conrad, U., Fett, W., Kurzeder, C., Lück, H-J., Stickeler, E., Urbaczyk, H., Liedtke, B., Beckmann, M. W., Salat, C., Harbeck, N., Müller, V., Schmidt, M., Hasmüller, S., Lenhard, M., Nekljudova, V., Lebeau, A., Loibl, S., Fasching, P. A. & Investigators, A. G. O. PREPARE., 2011, In: ANN ONCOL. 22, 9, p. 1999-2006 9.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Prognostic value of intercellular adhesion molecule (ICAM)-1 expression in breast cancer.
Schröder, C., Witzel, I., Müller, V., Krenkel, S., Wirtz, R. M., Jänicke, F., Schumacher, U. & Milde-Langosch, K., 2011, In: J CANCER RES CLIN. 137, 8, p. 1193-1201 8.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer.
Müller, V., Riethdorf, S., Rack, B., Janni, W., Fasching, P. A., Solomayer, E., Aktas, B., Kasimir-Bauer, S., Zeitz, J., Pantel, K., Fehm, T. & Group, DETECT. S., 2011, In: BREAST CANCER RES. 13, 4, p. 71 4.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin
Henningsen, M., Kilic, E., Koehler, N., Löning, T., Witzel, I., Hagel, C., Höller, S., Kersten, J. F., Müller, V., Jänicke, F. & Milde-Langosch, K., 2011, In: J CLIN PATHOL. 64, 2, p. 146-152 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancer.
Kock, L., Mahner, S., Choschzick, M., Zu Eulenburg, C. G., Milde-Langosch, K., Schwarz, J., Jänicke, F., Müller, V. & Wölber, L., 2011, In: INT J GYNECOL CANCER. 21, 1, p. 141-148 1.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2010
Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer.
Roth, C., Rack, B., Müller, V., Janni, W., Pantel, K. & Schwarzenbach, H., 2010, In: BREAST CANCER RES. 12, 6, p. 90 6.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.
Henningsen, M., Wirtz, R. M., Kalogeras, K. T., Milde-Langosch, K., Schmidt, M., Witzel, I., Eleftheraki, A. G., Papadimitriou, C., Jänicke, F., Briassoulis, E., Pectasides, D., Rody, A., Fountzilas, G. & Müller, V., 2010, In: BRIT J CANCER. 103, 7, p. 1048-1056 7.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome.
Witzel, I., Milde-Langosch, K., Wirtz, R. M., Roth, C., Henningsen, M., Mahner, S., Zu Eulenburg, C. G., Jänicke, F. & Müller, V., 2010, In: J CANCER RES CLIN. 136, 11, p. 1709-1718 11.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.
Riethdorf, S., Müller, V., Zhang, L., Rau, T., Loibl, S., Komor, M., Roller, M., Huober, J., Fehm, T., Schrader, I., Hilfrich, J., Holms, F., Tesch, H., Eidtmann, H., Untch, M., von Minckwitz, G. & Pantel, K., 2010, In: CLIN CANCER RES. 16, 9, p. 2634-2645 9.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review